HIPEC: Clinical Trials

3 trials of HIPEC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Active not recruiting 1, Recruiting 1, Terminated 1

Follow HIPEC: new trials by email Literature Review of HIPEC trials Research Report on HIPEC

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
HIPEC - Gallbladder Adenocarcinoma
Early Phase 1RecruitingWest Virginia University102022-06-232026-04-20
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Carboplatin, Cisplatin, Cytoreductive Surgery - Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma
Early Phase 1Active not recruitingOhio State University Comprehensive Cancer Center352022-06-132026-08-17
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Cisplatin, Cytoreductive Surgery, Doxorubicin - Malignant Abdominal Neoplasm, Malignant Pelvic Neoplasm
Early Phase 1TerminatedMayo Clinic22019-11-082025-02-20

Conditions studied

Fallopian Tube Neoplasms (2)  ·  Ovarian Neoplasms (2)  ·  Colonic Neoplasms (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Liposarcoma (1)  ·  Mesothelioma, Malignant (1)  ·  Pelvic Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Sponsors

Mayo Clinic (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  West Virginia University (1)

Countries

United States (3)

Top investigators

Brian Boone, MD (1)  ·  Floor Backes, MD (1)  ·  Patricio C. Gargollo, M.D. (1)